Anika Therapeutics
ANIK
#9072
Rank
โ‚ฌ0.16 B
Marketcap
12,10ย โ‚ฌ
Share price
-2.50%
Change (1 day)
46.71%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): -0,22ย โ‚ฌ

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -0,24ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,69ย โ‚ฌ an increase over its 2024 EPS that were of -3,51ย โ‚ฌ.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,22ย โ‚ฌ-68.24%
2025-0,69ย โ‚ฌ-80.26%
2024-3,51ย โ‚ฌ-31.86%
2023-5,15ย โ‚ฌ448.54%
2022-0,94ย โ‚ฌ-455.17%
20210,26ย โ‚ฌ-115.68%
2020-1,69ย โ‚ฌ-195.85%
20191,76ย โ‚ฌ48.46%
20181,18ย โ‚ฌ-40.37%
20171,99ย โ‚ฌ-1.8%
20162,02ย โ‚ฌ7.77%
20151,88ย โ‚ฌ-21.37%
20142,39ย โ‚ฌ74.67%
20131,37ย โ‚ฌ70.45%
20120,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-2,669.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
3,72ย โ‚ฌ-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
8,61ย โ‚ฌ-3,734.62%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
3,21ย โ‚ฌ-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA